These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 41236)

  • 1. [Conditions for ethionamide activity and the formation of resistant Mycobacterium tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1979 Oct; (10):58-60. PubMed ID: 41236
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of the 1314TH resistant media].
    Hayashi N; Inada S; Kobayashi H; Hara M; Yamagiwa N
    Iryo; 1969 Feb; 23(2):179-82. PubMed ID: 4979517
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of temperature and period of preservation of resistant media on minimal inhibitory concentration of alpha-ethyl-thioisonicotinamide (1314 th) to the growth of Mycobacterium tuberculosis].
    Tamura M; Yamazaki A
    Kekkaku; 1967 May; 42(5):165-72. PubMed ID: 4964920
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the susceptibility of secondary anti-tuberculosis drugs (with special reference to the resistance-stabilities of cycloserine and ethionamide-resistant bacilli)].
    Hayashi S
    Kumamoto Igakkai Zasshi; 1970 Feb; 44(2):135-43. PubMed ID: 4986047
    [No Abstract]   [Full Text] [Related]  

  • 6. [Criteria of mycobacterium resistance to thioacetazone and cross resistance to ethionamide].
    Afanas'eva IuP; Mkrtchian SV
    Probl Tuberk; 1969; 47(3):66-9. PubMed ID: 4982181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
    Mkrtchian SV
    Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Flory M
    Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of pH of the medium and other factors on the selection of isoniazid-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1975; (9):68-71. PubMed ID: 6956
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on thiacetazone resistance of tubercle bacilli. 3. Cross resistance between thiacetazone and ethionamide].
    Osato T; Tsukagoshi K; Shimizu H
    Kekkaku; 1971 Apr; 46(4):89-92. PubMed ID: 4102105
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the instability of ethionamide resistance and on the stability of other drug resistances in tubercle bacilli (five to nine years' in vitro observations)].
    Tsukamura M; Tsukamura S
    Kekkaku; 1967 Jan; 42(1):23-7. PubMed ID: 4962455
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
    Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
    J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies in guinea pigs on the resistance of tubercle bacilli to ethionamide].
    Janowiec M; Krakówka P
    Gruzlica; 1965 Apr; 33(4):273-6. PubMed ID: 4953732
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the sensitivity to ethionamide, thiacetazone and isoxyl of tubercle bacilli from previously untreated patients in Tokyo.
    Fukuhara Y; Kobayashi H; Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):57-61. PubMed ID: 4097677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 17. [The proportion method of determination of the resistance of tubercle bacilli to ethionamide, cycloserine and viomycin].
    Zduńczyk-Pawelek H
    Gruzlica; 1966 Mar; 34(3):255-63. PubMed ID: 4287801
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of certain conditions on the development of streptomycin-resistant forms of M. tuberculosis].
    Dolzhanskiĭ VM
    Probl Tuberk; 1973; 51(2):64-9. PubMed ID: 4203998
    [No Abstract]   [Full Text] [Related]  

  • 20. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
    Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
    Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.